Jimin Health Management Co., Ltd. Announces Resolutions of the Third Meeting of the Sixth Board of Directors

Log in to the Sina Finance APP and search for [Disclosure] to see more evaluation levels.

Stock code: 603222 Stock name: Jimin Health Announcement No.: 2026-009

Jimin Health Management Co., Ltd.

Announcement of the Resolution of the Third Meeting of the Sixth Board of Directors

The board of directors of the company and all directors guarantee that there are no false records, misleading statements, or significant omissions in the content of this announcement, and they bear individual and joint responsibility for the authenticity, accuracy, and completeness of its content.

1. Situation of the board meeting:

The third meeting of the sixth board of directors of Jimin Health Management Co., Ltd. (hereinafter referred to as “the Company”) was held on March 17, 2026, by communication voting. The meeting notice was sent out on March 13, 2026, via telephone, email, and written form. The meeting was chaired by Mr. Xu Zan, the chairman of the board. Nine directors were supposed to attend, and nine directors actually attended. The convening and holding of the meeting complied with the relevant provisions of the Company Law and the Articles of Association, making the meeting legal and valid.

2. Situation of the board meeting deliberation:

After careful deliberation by the attending directors, the following resolutions were formed:

(i) The proposal on “Increasing Capital and Introducing Strategic Investors for Subsidiaries and Related Transactions” was reviewed and approved with 9 votes in favor, 0 votes against, and 0 abstentions.

Before the proposal was submitted for board review, all independent directors held a special meeting to conduct a prior review of this related transaction.

(ii) The “Shareholder Return Plan for the Next Three Years (2026-2028)” was reviewed and approved with 9 votes in favor, 0 votes against, and 0 abstentions.

(iii) The proposal on “Amending the ‘Compensation Management System for Directors and Senior Management’” was reviewed and approved with 9 votes in favor, 0 votes against, and 0 abstentions.

(iv) The proposal on “Holding the Company’s First Extraordinary Shareholders’ Meeting in 2026” was reviewed and approved with 9 votes in favor, 0 votes against, and 0 abstentions.

This is hereby announced.

Board of Directors of Jimin Health Management Co., Ltd.

March 18, 2026

Stock code: 603222 Stock name: Jimin Health Announcement No.: 2026-010

Jimin Health Management Co., Ltd.

Announcement on Increasing Capital and Introducing Strategic Investors for Subsidiaries

and Related Transactions

The board of directors of the company and all directors guarantee that there are no false records, misleading statements, or significant omissions in the content of this announcement, and they bear legal responsibility for the authenticity, accuracy, and completeness of its content.

Important content reminder:

● Jimin Health Management Co., Ltd. (hereinafter referred to as “Jimin Health” or “the Company”) intends to introduce strategic investor Hubei Changhe Military-Civilian Innovative Medical Technology Co., Ltd. (hereinafter referred to as “Changhe Military-Civilian Innovation” or “the Investor”) for its wholly-owned subsidiary, Ezhou Second Hospital Co., Ltd. (hereinafter referred to as “Ezhou Second Hospital” or “the Target Company”). The Investor intends to increase capital to Ezhou Second Hospital with cash of 182,606,000 yuan based on a pre-investment valuation of 273,981,400 yuan. After the capital increase, Changhe Military-Civilian Innovation will hold 40% of the equity in Ezhou Second Hospital, and the company will hold 60% of the equity.

● This capital increase does not harm the interests of the company and all shareholders, especially minority shareholders, and complies with the provisions of the Company Law, the Shanghai Stock Exchange Stock Listing Rules, and the Articles of Association.

● The company waives its preemptive rights for this capital increase and, after the investor completes this capital increase, the company will still hold 60% of the shares in Ezhou Second Hospital, which will continue to be a subsidiary of the company.

● The introduced strategic investor, Changhe Military-Civilian Innovation, is an investment enterprise of the company’s invested entity, Hubei Changhe Intelligent Technology Venture Development Partnership (Limited Partnership) (the company currently holds 40.54%), and is a related party of the company. This transaction constitutes a related party transaction.

● This transaction does not constitute a major asset restructuring.

● This transaction has been reviewed and approved by the third meeting of the sixth board of directors and needs to be submitted to the shareholders’ meeting for review.

● In the past 12 months, the company has not had similar related party transactions with the related party Changhe Military-Civilian Innovation.

● As of the disclosure date of this announcement, Ezhou Second Hospital has received the first installment of the investment of 18,260,600 yuan prepaid by Changhe Military-Civilian Innovation. This transaction has been approved by the third meeting of the sixth board of directors and still needs to be submitted to the shareholders’ meeting for review. Subsequently, if the relevant parties do not timely perform their rights and obligations as agreed in the contract, it may lead to delays in the transaction progress or even failure to complete the transaction smoothly, thus there is still some uncertainty in this transaction. Investors are kindly reminded to invest rationally and pay attention to investment risks.

1. Overview of related party transactions

(i) Basic situation of this transaction

To strengthen the capital strength of Ezhou Second Hospital and optimize its equity structure, Ezhou Second Hospital intends to introduce strategic investor Changhe Military-Civilian Innovation through capital increase. Changhe Military-Civilian Innovation intends to increase capital to Ezhou Second Hospital with cash of 182,606,000 yuan based on a pre-investment valuation of 273,981,400 yuan. After the capital increase, Changhe Military-Civilian Innovation will hold 40% of the shares in Ezhou Second Hospital, and the company will still hold 60% of the equity, with Ezhou Second Hospital changing from a wholly-owned subsidiary to a controlling subsidiary of the company, and the scope of the company’s consolidated financial statements will not change.

The capital increase price is determined based on the asset appraisal report No. 52155 issued by Zhongtong Cheng Asset Appraisal Co., Ltd., which evaluates the total equity value of Ezhou Second Hospital at 273,981,400.00 yuan, with the price corresponding to every 1 yuan of registered capital being: evaluated net asset value ÷ current registered capital = 273,981,400.00 ÷ 238,000,000.00 ≈ 1.1512 yuan.

(ii) Explanation of related relationships

Currently, the company holds 40.54% of the equity in Hubei Changhe Intelligent Technology Venture Development Partnership (Limited Partnership) (hereinafter referred to as “Changhe Intelligent Technology”), which holds 40% of the equity in Changhe Military-Civilian Innovation. Therefore, Changhe Military-Civilian Innovation is a related party of the company, and this transaction constitutes a related party transaction.

(iii) Meeting deliberation situation

The company held the third meeting of the sixth board of directors on March 17, 2026, and the proposal on “Increasing Capital and Introducing Strategic Investors for Subsidiaries and Related Transactions” was reviewed and approved with 9 votes in favor, 0 votes against, and 0 abstentions. Before the above proposal was submitted for board review, all independent directors held a special meeting to conduct a prior review of this related party transaction, which was unanimously agreed upon by all independent directors and subsequently submitted to the board for review.

This transaction still needs to be submitted for approval by the shareholders’ meeting.

(iv) In the past 12 months, the company has not had similar related party transactions with the related party Changhe Military-Civilian Innovation.

2. Information about the trading counterparties

(i) Basic situation of trading counterparties

■

(ii) Main financial data of the trading party

Unit: Ten thousand yuan

■

3. Basic situation of the related party transaction targets

(i) Basic situation of transaction targets

■

(ii) Main financial data of transaction targets

Unit: Ten thousand yuan

■

4. Evaluation and pricing situation of transaction targets

(i) Evaluation and pricing situation of transaction targets

The asset appraisal report No. 52155 issued by Zhongtong Cheng Asset Appraisal Co., Ltd. evaluates the total equity value of Ezhou Second Hospital at 273,981,400 yuan. The assessed value of the total equity of the shareholders has increased by 30,369,400 yuan compared to the book value, with an appreciation rate of 12.47%, mainly due to the increase in the assessed value of intangible assets (land use rights) compared to the book value.

All parties unanimously agree that the capital increase price is negotiated based on the aforementioned assessed net asset value, with the price corresponding to every 1 yuan of registered capital being: assessed net asset value ÷ current registered capital = 273,981,400.00 ÷ 238,000,000.00 ≈ 1.1512 yuan.

(ii) Analysis of pricing rationality

The pricing of this transaction is based on the “Asset Appraisal Report on the Total Equity Value of Ezhou Second Hospital Involved in the Equity Acquisition by Hubei Changhe Military-Civilian Innovation Medical Technology Co., Ltd.” The transaction pricing is reasonable and does not harm the interests of the company and shareholders, especially minority shareholders.

5. Main contents and performance arrangements of the capital increase agreement

(i) Agreement parties

Party A (Investor): Hubei Changhe Military-Civilian Innovative Medical Technology Co., Ltd.

Party B (Original Shareholder): Jimin Health Management Co., Ltd.

Party C (Target Company): Ezhou Second Hospital Co., Ltd.

The asset appraisal report No. 52155 issued by Zhongtong Cheng Asset Appraisal Co., Ltd. evaluates the total equity value of Ezhou Second Hospital at the appraisal benchmark date of September 30, 2025, at 273,981,400.00 yuan.

(ii) Capital increase plan

1. Method and price of capital increase

Party A will increase capital to Party C in cash. The capital increase price is negotiated based on the aforementioned assessed net asset value, with the price corresponding to every 1 yuan of registered capital being: assessed net asset value ÷ Party C’s current registered capital = 273,981,400.00 ÷ 238,000,000.00 ≈ 1.1512 yuan.

2. Amount of capital increase and equity ratio

The total amount of capital increase by Party A is 182,606,000 yuan (the “Capital Increase Payment”). Among this capital increase payment, 158,667,000 yuan will be included in Party C’s registered capital, while the remaining amount will be included in Party C’s capital surplus.

After the completion of this capital increase, Party A will hold 40% of the shares in Party C.

(iii) Payment and delivery of capital increase payment

1. First payment: Within ten (10) working days from the signing date of the capital increase agreement between Party A and Party B, Party A will pay 10% of the total capital increase payment to Party C;

2. Second payment: Within ten (10) working days from the date when this capital increase is approved by the resolution of Party B’s shareholders’ meeting and the relevant resolution documents are formally delivered to Party A, Party A will pay 50% of the total capital increase payment to Party C;

3. Third payment: Within ten (10) working days from the date when Party C completes the industrial and commercial change, Party A will pay 35% of the total capital increase payment to Party C;

4. Fourth payment: Within ten (10) working days from the date when Party C completes the board reorganization as stipulated in Article 6 of this agreement, Party A will pay 5% of the total capital increase payment to Party C.

After Party C receives each payment from Party A, it shall issue a receipt stamped with a financial special seal within three (3) working days.

All parties shall do their utmost to cooperate to ensure that Party C initiates the industrial and commercial change registration procedures for this capital increase within three (3) working days after Party A pays the third payment, and Party C shall complete the industrial and commercial change registration procedures for this capital increase within 30 days.

(iv) Confirmation of asset appraisal and audit

1. All parties confirm that they have received and reviewed the “Appraisal Report,” recognize the contents and conclusions stated in the report, and agree to use the assessed net asset value stated in the report as the basis for determining the capital increase price.

2. All parties confirm that the matters disclosed in Article 11 “Special Matters Description” of the “Appraisal Report” (including but not limited to ownership defects of certain properties, external guarantees, leasing and borrowing, etc.) have been fully considered when determining the capital increase price and signing this agreement. Party B and Party C guarantee that, except for the matters disclosed in the “Appraisal Report,” Party C has no other undisclosed significant liabilities, contingent liabilities, guarantees, litigations, or asset ownership defects.

(v) Governance arrangements for the target company

The target company shall establish a board of directors with 5 members, with Party A nominating 2 directors and Party B nominating 3 directors; the chairman shall be a director nominated by Party B, who shall serve as the legal representative of the target company; the company shall implement a general manager responsibility system under the leadership of the board of directors, with one general manager appointed by Party A.

(vi) Liability for breach of contract

All parties shall strictly perform the obligations stipulated in this agreement based on the principle of good faith. If any party fails to perform the obligations stipulated in this agreement or performs them in a manner that does not comply with the agreement, it shall be deemed to be in breach of contract. Unless otherwise stipulated in this agreement, the non-breaching party has the right to unilaterally terminate this agreement, and the breaching party shall compensate the other party for the losses incurred thereby, including but not limited to actual losses and attorney fees, litigation fees, asset preservation fees, preservation guarantee fees, preservation insurance fees, announcement fees, etc.

(vii) Effectiveness, modification, and termination of the agreement

This agreement shall take effect upon the signatures and official seals of all parties and shall become effective when the capital increase matter is approved by the shareholders’ meetings of Parties A and B.

Any modification or supplement to this agreement must be made in writing by all parties and shall have the same legal effect as this agreement.

Unless otherwise stipulated in this agreement, neither party shall transfer its shares in Party C to any third party without the written consent of Parties A and B.

6. Impact on the listed company

This capital increase is in line with the actual operation and future development needs of the company and Ezhou Second Hospital, which is beneficial to enhance the capital strength of Ezhou Second Hospital and optimize the company’s governance structure, in line with the company’s strategic development plan. After the completion of this capital increase, Ezhou Second Hospital will change from a wholly-owned subsidiary to a controlling subsidiary, and the scope of the company’s consolidated financial statements will remain unchanged.

7. Risk reminder

As of the disclosure date of this announcement, Ezhou Second Hospital has received the first installment of investment of 18,260,600 yuan prepaid by Changhe Military-Civilian Innovation. This transaction has been approved by the third meeting of the sixth board of directors and still needs to be submitted to the shareholders’ meeting for review. Subsequently, if the relevant parties do not timely perform their rights and obligations as agreed in the contract, it may lead to delays in the transaction progress or even failure to complete the transaction smoothly, thus there is still some uncertainty in this transaction.

The company will fulfill its information disclosure obligations in a timely manner according to relevant laws and regulations. Investors are kindly reminded to invest rationally and pay attention to investment risks.

This is hereby announced.

Board of Directors of Jimin Health Co., Ltd.

March 18, 2026

Stock code: 603222 Stock name: Jimin Health Announcement No.: 2026-011

Jimin Health Management Co., Ltd.

Notice of the First Extraordinary Shareholders’ Meeting in 2026

The board of directors of the company and all directors guarantee that there are no false records, misleading statements, or significant omissions in the content of this announcement, and they bear legal responsibility for the authenticity, accuracy, and completeness of its content.

Important content reminder:

● Date of the shareholders’ meeting: April 2, 2026

● Online voting system used for this shareholders’ meeting: Shanghai Stock Exchange Shareholders’ Meeting Online Voting System

1. Basic situation of the meeting

(i) Type and session of the shareholders’ meeting

First extraordinary shareholders’ meeting of 2026

(ii) Convener of the shareholders’ meeting: Board of Directors

(iii) Voting method: The voting method used for this shareholders’ meeting is a combination of on-site voting and online voting.

(iv) Date, time, and location of the on-site meeting

Date and time of the meeting: April 2, 2026, at 14:00

Location: Meeting Room on the 4th Floor of the Administrative Building, No. 888 North Courtyard Road, Huangyan District, Taizhou City, Zhejiang Province

(v) Network voting system, start and end dates, and voting time.

Network voting system: Shanghai Stock Exchange Shareholders’ Meeting Online Voting System

Network voting start and end time: From April 2, 2026, to April 2, 2026.

Voting time through the trading system voting platform is during the trading hours of the shareholders’ meeting on the same day, i.e., 9:15-9:25, 9:30-11:30, 13:00-15:00; voting time through the internet voting platform is from 9:15 to 15:00 on the same day.

(vi) Voting procedures for margin trading, transfer, and repurchase accounts and Shanghai Stock Connect investors

Voting involving margin trading, transfer, repurchase accounts, and voting by Shanghai Stock Connect investors should be implemented in accordance with the “Self-Regulatory Guidelines No. 1 for Listed Companies of Shanghai Stock Exchange - Standardized Operation” and other relevant regulations.

(vii) Involvement of public solicitation of shareholder voting rights

None

2. Matters to be deliberated at the meeting

The proposals to be reviewed at this shareholders’ meeting and the types of voting shareholders

■

1. Time and media of disclosure for each proposal

The company disclosed relevant announcements in “Shanghai Securities News” and on the Shanghai Stock Exchange website on March 18, 2026.

2. Special resolutions: None

3. Proposals for separate voting by minority investors: None

4. Proposals involving related shareholders abstaining from voting: None

Names of related shareholders who should abstain from voting: None

5. Proposals involving preferred shareholders participating in voting: None

6. Voting precautions for the shareholders’ meeting

(i) Shareholders of the company can exercise their voting rights through the Shanghai Stock Exchange Shareholders’ Meeting Online Voting System by logging into the trading system voting platform (via designated trading securities company trading terminals) to vote, or by logging into the internet voting platform (website: vote.sseinfo.com) to vote. Investors need to complete shareholder identity verification to vote on the internet voting platform for the first time. Please refer to the website instructions of the internet voting platform for specific operations.

To better serve the majority of minority investors and ensure that minority investors who wish to vote can attend and vote in a timely manner, the company uses the shareholder meeting reminder service provided by Shanghai Stock Exchange Information Co., Ltd. (hereinafter referred to as “Shanghai Stock Exchange Information”) to proactively remind shareholders to attend the meeting and vote through intelligent SMS and other means based on the shareholder list on the registration date, sending every investor proactive invitations to the shareholders’ meeting, proposal information, and other details. After receiving the intelligent SMS, investors can refer to the user manual (download link:

(ii) The same voting right repeated through on-site, online voting platform, or other means will be based on the result of the first vote.

(iii) Shareholders holding multiple shareholder accounts can exercise voting rights based on the total number of common stocks and preferred stocks of the same category held across all their accounts.

Shareholders holding multiple accounts participating in online voting through the stock exchange’s voting system can participate through any of their shareholder accounts. After voting, it is deemed that voting preferences have been cast for the same category of common stocks and preferred stocks across all accounts.

Shareholders holding multiple accounts and voting repeatedly through multiple accounts will have their voting opinions counted based on the first voting result for each category and type of stock across all accounts.

(iv) Shareholders must complete voting on all proposals before submission.

4. Attendees of the meeting

(i) Shareholders registered with China Securities Depository and Clearing Co., Ltd. Shanghai Branch at the close of trading on the registration day have the right to attend the shareholders’ meeting (detailed situation see below) and may appoint an agent in writing to attend the meeting and participate in voting. The agent need not be a shareholder of the company.

■

(ii) Company directors and senior management personnel.

(iii) Lawyers hired by the company.

(iv) Other personnel.

5. Registration method for the meeting

(i) Attending shareholders (including shareholder agents) need to provide the following documents when registering or checking in:

1. Individual shareholders attending the meeting should bring their ID card and shareholder account card; if appointing an agent to attend, the agent should bring the principal’s original or photocopied ID, the agent’s original ID, the original power of attorney, and the principal’s shareholder account card.

2. If a legal person shareholder attends the meeting in person, they should bring their ID card, a photocopy of the business license (stamped), and the shareholder account card; if the agent attends, the agent should hold their ID card, the power of attorney issued by the legal representative of the corporate shareholder stamped with the legal person seal or signed by the legal representative, and the shareholder account card for registration.

3. Margin trading investors attending the meeting should bring the business license of the relevant securities company, proof of securities account, and the power of attorney issued to investors; if the investor is an individual, they should also carry their ID or other valid documents to identify themselves, and if the investor is an organization, they should bring the organization’s business license, ID of the attendees, and the power of attorney issued by the legal representative of the unit.

The power of attorney can be found in Attachment 1.

(ii) Registration time

April 1, 2026, from 9:30 to 11:30 AM, and from 1:00 to 5:00 PM

(iii) Registration location

Meeting Room on the 4th Floor of the Administrative Building, No. 888 North Courtyard Avenue, Huangyan District, Taizhou City, Zhejiang Province

(iv) Shareholders may register by fax or letter (relevant documents must be provided), and registration by fax or letter is based on the time the company receives it within the registration time. Please indicate a contact number on the fax or letter.

6. Other matters

7. The meeting will last half a day, and accommodation expenses are self-catered.

8. Contact person: Pan Min Contact number: 0576-84066800 Fax: 0576-84066666

9. Shareholders registering by fax should indicate the contact number and contact person on the fax.

10. Postal code: 318020

This is hereby announced.

Board of Directors of Jimin Health Management Co., Ltd.

March 18, 2026

Attachment 1: Power of Attorney

● Filing documents

Resolution of the board of directors proposing to convene this shareholders’ meeting

Attachment 1: Power of Attorney

Power of Attorney

Jimin Health Management Co., Ltd.:

I hereby appoint Mr./Ms. to represent this unit (or myself) at the first extraordinary shareholders’ meeting of your company held on April 2, 2026, and to exercise voting rights on my behalf.

Number of common shares held by the principal:

Number of preferred shares held by the principal:

Principal’s shareholder account number:

■

Principal’s signature (seal): Agent’s signature:

Principal’s ID number: Agent’s ID number:

Date of authorization: Year Month Day

Note:

The principal should select one of the options “Agree,” “Disagree,” or “Abstain” in the power of attorney and mark “√.” For any specific instructions not made by the principal in this power of attorney, the agent has the right to vote at their discretion.

Massive information, precise interpretation, all in the Sina Finance APP.